TECH
Price:
$71.49
Market Cap:
$11.34B
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of ma...[Read more]
Industry
Biotechnology
IPO Date
1989-02-09
Stock Exchange
NASDAQ
Ticker
TECH
According to Bio-Techne Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 68.09. This represents a change of -5.66% compared to the average of 72.17 of the last 4 quarters.
The mean historical PE Ratio of Bio-Techne Corporation over the last ten years is 58.77. The current 68.09 PE Ratio has changed 11.49% with respect to the historical average. Over the past ten years (40 quarters), TECH's PE Ratio was at its highest in in the June 2021 quarter at 292.76. The PE Ratio was at its lowest in in the December 2019 quarter at 17.51.
Average
58.77
Median
47.47
Minimum
33.91
Maximum
124.26
Discovering the peaks and valleys of Bio-Techne Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 182.43%
Maximum Annual PE Ratio = 124.26
Minimum Annual Increase = -59.78%
Minimum Annual PE Ratio = 33.91
Year | PE Ratio | Change |
---|---|---|
2024 | 67.18 | 49.36% |
2023 | 44.98 | -9.99% |
2022 | 49.97 | -59.78% |
2021 | 124.26 | 182.43% |
2020 | 44.00 | -46.54% |
2019 | 82.30 | 86.05% |
2018 | 44.24 | -22.03% |
2017 | 56.74 | 41.34% |
2016 | 40.14 | 18.38% |
2015 | 33.91 | 10.18% |
The current PE Ratio of Bio-Techne Corporation (TECH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
54.04
5-year avg
66.08
10-year avg
58.77
Bio-Techne Corporation’s PE Ratio is greater than BioMarin Pharmaceutical Inc. (62.30), greater than Vaxcyte, Inc. (-26.31), greater than Liquidia Corporation (-6.20), greater than Legend Biotech Corporation (-30.94), greater than Seagen Inc. (-57.36), greater than Alnylam Pharmaceuticals, Inc. (-428.77), greater than Exelixis, Inc. (20.78), greater than Halozyme Therapeutics, Inc. (22.31), greater than Replimune Group, Inc. (-3.26), greater than Nuvalent, Inc. (-32.10), greater than Ventyx Biosciences, Inc. (-0.89), greater than Ascendis Pharma A/S (-12.57), greater than United Therapeutics Corporation (14.35), greater than Apellis Pharmaceuticals, Inc. (-15.28), greater than BeiGene, Ltd. (-38.25), greater than Akero Therapeutics, Inc. (-8.95), greater than Blueprint Medicines Corporation (-26.44), greater than Travere Therapeutics, Inc. (-5.83),
Company | PE Ratio | Market cap |
---|---|---|
62.30 | $16.01B | |
-26.31 | $12.45B | |
-6.20 | $698.44M | |
-30.94 | $9.90B | |
-57.36 | $43.15B | |
-428.77 | $31.68B | |
20.78 | $7.17B | |
22.31 | $7.50B | |
-3.26 | $708.49M | |
-32.10 | $5.59B | |
-0.89 | $153.35M | |
-12.57 | $6.83B | |
14.35 | $15.38B | |
-15.28 | $5.00B | |
-38.25 | $21.01B | |
-8.95 | $1.83B | |
-26.44 | $5.47B | |
-5.83 | $839.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Techne Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bio-Techne Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bio-Techne Corporation's PE Ratio?
How is the PE Ratio calculated for Bio-Techne Corporation (TECH)?
What is the highest PE Ratio for Bio-Techne Corporation (TECH)?
What is the 3-year average PE Ratio for Bio-Techne Corporation (TECH)?
What is the 5-year average PE Ratio for Bio-Techne Corporation (TECH)?
How does the current PE Ratio for Bio-Techne Corporation (TECH) compare to its historical average?